Found vs Hims & Hers: November 2026 prices compared
As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only Found prints a comparable month-to-month price, $339 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.
Released · Last reviewed · how we verify
On compounded semaglutide, only Found prints a comparable month-to-month price, $269 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.
Found and Hims & Hers, measure by measure
| Measure | Found | Hims & Hers |
|---|---|---|
| Tirzepatide, month to month | $339 (per 28-day cycle) | — |
| Tirzepatide, lowest printed | $199 (12-month term, per 28-day cycle) | — |
| Semaglutide, month to month | $269 (per 28-day cycle) | — |
| Semaglutide, lowest printed | $149 (12-month term, per 28-day cycle) | — |
| Dose pricing | priced by dose or not stated | not confirmed |
| Membership or program fee | none | not confirmed |
| Computed score | 21 of 40 (position 12 of 27) | not scored (brand route) |
| FDA warning letters | none listed | 716567 (2025-09-09); 716825 (2025-09-09) |
| November 20 read | first-party read, changed | not readable Nov 20 |
Strengths and limitations: which fits whom
Found bills every 28 days, which adds a 13th charge to the year. Hims & Hers suits someone who wants brand medication, FDA-approved, and accepts a higher monthly cost or has coverage. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.
What changed since August
The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.
| Program | Medication | August 5–10, 2026 | November 20, 2026 |
|---|---|---|---|
| Found | tirzepatide | — | $339 |
| Found | semaglutide | — | $269 |
Regulatory record
FDA’s warning-letter index lists warning letter 716567 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) and warning letter 716825 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) to Hims & Hers; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.
Frequently asked
Which is cheaper, Found or Hims & Hers?
On compounded tirzepatide, only Found prints a comparable month-to-month price, $339 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible. On compounded semaglutide, only Found prints a comparable month-to-month price, $269 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.
Do Found and Hims & Hers charge a membership fee?
Found: no membership fee; Hims & Hers: not confirmed on November 20, 2026. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.
Are Found and Hims & Hers medications FDA-approved?
Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- Found pricing page (read November 20, 2026)
- Hims & Hers pricing page (not readable on November 20, 2026)
- FDA warning letter 716567 to Hims & Hers (dated 2025-09-09, posted 2025-09-16)
- FDA warning letter 716825 to Hims & Hers (dated 2025-09-09, posted 2025-09-16)